Navigation Links
Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012
Date:4/12/2012

TARRYTOWN, N.Y., April 12, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2012 financial and operating results on Thursday, April 26, 2012, before the U.S. financial markets open.  The Company will host a conference call at 8:30 AM EDT that day.

Live audio of the conference call will be webcast online simultaneously.  A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com.  A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days.  

Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets two products in the United States, one for the treatment of neovascular (wet) age-related macular degeneration and another for the treatment of a rare inflammatory condition.  Additionally, Regeneron has three regulatory applications pending before the U.S. Food and Drug Administration (FDA) and 10 drug candidates in clinical development.  More information and recent news releases are available on the Regeneron website at www.regeneron.com. Contact Information:Manisha Narasimhan, Ph.D.Peter DworkinInvestor RelationsCorporate Communications914-847-512914.847.764Manisha.narasimhan@regeneron.competer.dworkin@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 13, 2014 Auf ... Tokio veranstalteten F&E-Tagung meldete Astellas ... Neuausrichtung seines Forschungsrahmenprogramms. Die Tagung bot Astellas ... fortgeschrittenen klinischen Programme und die Konzernstrategie des ... bestand darin, aktuelle Meldungen zu den Astellas-Initiativen ...
(Date:7/11/2014)... N.C. , July 11, 2014 ... approaches are evolving across industry sectors to better ... examining better ways to engage with and understand ... inform themselves and make critical purchasing decisions. ... firm, Best Practices, LLC, one area where organizations ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... "Global Hypodermic Needles Market 2014-2018" report to ... A hypodermic needle is a hollow needle ... the body or or to extract fluids from it. ... liquids or to inject substances that cannot be ingested. ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Technologies Transforming Consumer Marketing Research Playbook 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
(Date:7/14/2014)... analysis has found that rates of testicular cancer have ... American men, but not among their non-Hispanic counterparts. Published ... of the American Cancer Society, the findings indicate that ... testicular cancer in Hispanic adolescents and young adults, and ... of this trend. , Testicular cancer is one of ...
(Date:7/14/2014)... 2014 According to the ... recently updated by Vkool.com, this is a ... range of simple and easy tips for ...     Increasing omega-3 fatty acids ... ,     Increasing fiber ,     Avoid ...
(Date:7/14/2014)... July 14, 2014 Vaginal Mesh ... against seven different pelvic mesh manufacturers in the U.S. ... & Schulte LLC. The federal complaints are pending against ... 2327), American Medical Systems (MDL No. 2325), and C.R. ... there are 58,262 Vaginal Mesh lawsuit claims pending, according ...
(Date:7/14/2014)... Bay, WI (PRWEB) July 14, 2014 ... recently announced the launch of their new company website. ... gather valuable free information on chiropractic marketing. It's also ... services that Inception has to offer. , When contacted ... release the newest version of our main website. Our ...
(Date:7/14/2014)... Texas (PRWEB) July 14, 2014 ... forefront in complete spine care—from diagnosis to treatment and ... locations are either certified in or training for certification ... Theresa Adame, have recently completed the extensive program. , ... utilizing The McKenzie Method results in better outcomes for ...
Breaking Medicine News(10 mins):Health News:Testicular cancer rates are on the rise in young Hispanic Americans 2Health News:Endometriosis Bible and Violet Protocol Book Review Exposes Zoe Brown's Endometriosis Treatment Guide – Vkool.com 2Health News:Endometriosis Bible and Violet Protocol Book Review Exposes Zoe Brown's Endometriosis Treatment Guide – Vkool.com 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 2Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 4Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 5Health News:Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3
... 27 A panel of leading asbestos litigators, ... this month in Beverly Hills to deliver a ... the most massive of toxic torts.The video, audio ... available from HB Litigation Conferences LLC, formerly Mealey,s ...
... Findings emphasize value of early screening programs, report concludes ... your blood pressure, the greater your risk of kidney ... data from the National Kidney Foundation,s Kidney Early Evaluation ... of chronic kidney disease are present once a person ...
... WINSTON-SALEM, N.C., March 27 Prince William Health ... Novant Health, both regional not-for-profit health systems, announced ... to merge. The partnership will provide the ... western Prince William County. "We chose to affiliate ...
... from public and private sector; Will work together to implement ... Anthem Blue Cross and Blue Shield and ... have joined with five other leading health organizations in Indiana ... fill the gaps in diabetes care by addressing health care ...
... food choices later on, study finds , , FRIDAY, March ... that kids in families that have at least five ... habits. , University of Minnesota researchers reported that adolescents ... healthful diets, meaning they consumed more vegetables, calcium-rich ...
... Emageon Inc. (Nasdaq: EMAG ), a leading provider ... that it and the other named defendants in the putative ... in connection with the proposed acquisition of Emageon by AMICAS, ... memorandum of understanding with counsel for the plaintiff.Pursuant to the ...
Cached Medicine News:Health News:HB Litigation Conferences LLC: Video of Much-Discussed Asbestos Litigation Debates & Discourse Now Available 2Health News:Kidney Ailments May Rise Along With Blood Pressure 2Health News:Prince William Health System and Novant Health Agree on Partnership to Expand Quality Healthcare in Northern Virginia 2Health News:Prince William Health System and Novant Health Agree on Partnership to Expand Quality Healthcare in Northern Virginia 3Health News:Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes 2Health News:Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes 3Health News:Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes 4Health News:Families That Eat Together Serve Up Good Dietary Habits 2Health News:Emageon Settles Shareholder Class Action Lawsuit 2Health News:Emageon Settles Shareholder Class Action Lawsuit 3Health News:Emageon Settles Shareholder Class Action Lawsuit 4
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
DMSO-resistant microplate sealing film...
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Medicine Products: